Response from the International Transporter Consortium

被引：0

作者：

Caroline A. Lee

Kathleen M. Hillgren

Lei Zhang

Joseph W. Polli

机构：

[1] Caroline A. Lee is at Pfizer Global Research and Development,

[2] La Jolla Laboratories,undefined

[3] 10724 Science Center Drive,undefined

[4] San Diego,undefined

[5] California 92121,undefined

[6] USA. caroline.lee01@pfizer.com,undefined

[7] Kathleen M. Hillgren is at Lilly Research Laboratories,undefined

[8] Lilly Corporate Center,undefined

[9] Indianapolis,undefined

[10] Indiana 46285,undefined

[11] USA. hillgren_kathleen_m@lilly.com,undefined

[12] Lei Zhang is at the Office of Clinical Pharmacology,undefined

[13] Office of Translational Sciences,undefined

[14] Center for Drug Evaluation and Research,undefined

[15] Food and Drug Administration,undefined

[16] 10903 New Hampshire Avenue,undefined

[17] Silver Spring,undefined

[18] Maryland 20993-0002,undefined

[19] USA. leik.zhang@fda.hhs.gov,undefined

[20] Joseph W. Polli is at PO Box 13398,undefined

[21] GlaxoSmithKline,undefined

[22] Research Triangle Park,undefined

[23] North Carolina 27709,undefined

[24] USA.,undefined

来源：

Nature Reviews Drug Discovery | 2011年 / 10卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：75 / 75

共 50 条

[1] Response from the International Transporter Consortium
Lee, Caroline A.
Hillgren, Kathleen M.
Zhang, Lei
Polli, Joseph W.
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (01) : 75 - 75
[2] INFLUENCE OF TRANSPORTER POLYMORPHISMS ON DRUG DISPOSITION AND RESPONSE: A PERSPECTIVE FROM THE INTERNATIONAL TRANSPORTER CONSORTIUM
Yee, Sook Wah
DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S1 - S1
[3] Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium
Yee, Sook Wah
Brackman, Deanna J.
Ennis, Elizabeth A.
Sugiyama, Yuichi
Kamdem, Landry K.
Blanchard, Rebecca
Galetin, Aleksandra
Zhang, Lei
Giacomini, Kathleen M.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 803 - 817
[4] Highlights from the International Transporter Consortium Second Workshop
Zamek-Gliszczynski, M. J.
Hoffmaster, K. A.
Tweedie, D. J.
Giacomini, K. M.
Hillgren, K. M.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (05) : 553 - 556
[5] International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms
Giacomini, K. M.
Balimane, P. V.
Cho, S. K.
Eadon, M.
Edeki, T.
Hillgren, K. M.
Huang, S-M
Sugiyama, Y.
Weitz, D.
Wen, Y.
Xia, C. Q.
Yee, S. W.
Zimdahl, H.
Niemi, M.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (01) : 23 - 26
[6] Transporters and Toxicity: Insights from the International Transporter Consortium Workshop 4
Hafey, Michael J.
Aleksunes, Lauren M.
Bridges, Christy C.
Brouwer, Kenneth R.
Chien, Huan-Chieh
Leslie, Elaine M.
Hu, Shuiying
Li, Yang
Shen, Jinshan
Sparreboom, Alex
Sprowl, Jason
Tweedie, Donald
Lai, Yurong
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (03) : 527 - 539
[7] Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium
Hillgren, K. M.
Keppler, D.
Zur, A. A.
Giacomini, K. M.
Stieger, B.
Cass, C. E.
Zhang, L.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (01) : 52 - 63
[8] The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA
Huang, S-M
Zhang, L.
Giacomini, K. M.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (01) : 32 - 36
[9] Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective
Schlessinger, Avner
Welch, Matthew A.
van Vlijmen, Herman
Korzekwa, Ken
Swaan, Peter W.
Matsson, Par
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 818 - 835
[10] Transporter Studies in Drug Development: Experience to Date and Follow-Up on Decision Trees From the International Transporter Consortium
Tweedie, D.
Polli, J. W.
Berglund, E. Gil
Huang, S. M.
Zhang, L.
Poirier, A.
Chu, X.
Feng, B.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (01) : 113 - 125

← 1 2 3 4 5 →